BLUHM CARDIOVASCULAR INSTITUTE

Revolution in Transcatheter Heart Valve Therapies

As one of the highest volume and most experienced transcatheter aortic heart valve replacement (TAVR) programs in the nation, Northwestern Medicine continues to expand its Transcatheter Heart Valve Program by offering a wide array of commercially available and clinical trials for the aortic, mitral and tricuspid valves.

LEARN MORE

Setting the Pace for Transcatheter Heart Valve Therapies

The Transcatheter Heart Valve Program at Northwestern Medicine offers a wide variety of commercially available (FDA approved) and clinical trial options for the aortic, mitral and tricuspid valves, allowing us to tailor treatment precisely to each patient’s individual needs.

The Transcatheter Heart Valve Program continues to grow, not only in therapies offered but also in locations. In addition to a number of transcatheter heart valve therapies being offered at Northwestern Memorial Hospital, transcatheter aortic valve therapy (TAVR) is now available at Central DuPage Hospital.

312.NM.HEART (664.3278) | heart.nm.org | Inquiries: BCVI_info@nm.org

All Rights Reserved. ©2017 by Northwestern Medicine® and Northwestern Memorial HealthCare. 

Northwestern Medicine® is a trademark of Northwestern Memorial HealthCare, used by Northwestern University.

Northwestern Medicine ® | 251 E Huron Street | Chicago, IL 60611 | nm.org

Meet the Team

Bluhm Cardiovascular Institute at Northwestern Memorial Hospital
675 N. Saint Clair Street
Galter Pavilion, Suite 19-100
Chicago, IL 60611
312.NM.HEART (664.3278)

Charles J. Davidson, MD
Interventional Cardiology
Procedures performed: TAVR, Aortic Valve in Valve, PARTNER, MitraClip, CardiAQ, TIARA, SCOUT

James D. Flaherty, MD
Interventional Cardiology
Procedures performed: TAVR, PARTNER, Aortic Valve in Valve, CardiAQ, TIARA

Transcatheter heart valve therapies are minimally invasive procedures to repair or replace a diseased heart valve that involves threading a catheter (tube) through a small incision made in the skin. The device needed to repair or replace the diseased valve is placed in the lumen of the catheter and feed through an artery in the body until it reaches the diseased heart valve.

Transcatheter heart valve therapies are for some people an alternative to open heart valve surgery. Transcatheter therapies allow the procedure to be performed while the patient’s heart is still beating, eliminating the need for a “bypass” machine and its associated risks. Transcatheter heart valve therapies are an especially important treatment option for people considered high risk for open heart valve surgery.

Transcatheter Heart Valve Procedures

Mitral Valve Transcatheter Treatment Options

MitraClip: commercially available 
A minimally invasive treatment option for patients with mitral regurgitation who are too high risk for open heart valve surgery. With mitral regurgitation the mitral valve does not close completely, allowing blood to flow backward or “leak,” creating symptoms that may include shortness of breath, fatigue and chest pain.

The MitraClip device is inserted in to the body through a catheter (tube) placed in the patient’s femoral (groin) vein. Once in the heart, the device is positioned and placed to join or “clip” together a portion of the mitral valve, reducing or eliminating the backward flow of blood.

Mitral Valve in Valve Replacement: commercially available
A minimally invasive transcatheter mitral valve replacement (TMVR) procedure for patients who have had previous open heart valve surgery to replace the mitral valve with a bioprosthetic/tissue valve and the tissue valve is now failing. Instead of the failing mitral valve being replaced during another open heart valve surgery, the failing mitral tissue valve is replaced by placing a TMVR valve inside the failing mitral tissue valve.

Mitral Valve Transcatheter Clinical Trials:
CardiAQ, offered at Northwestern Memorial Hospital for select patients needing mitral valve replacement
COAPT, offered at Northwestern Memorial Hospital for select patients with mitral valve regurgitation
TIARA-I, offered at Northwestern Memorial Hospital for select patients with mitral valve regurgitation

MitraClip in place clipping together a portion of the mitral valve

Aortic Valve Transcatheter Treatment Options

Transcatheter Aortic Valve Replacement (TAVR): commercially available
A minimally invasive treatment option for patients with aortic valve stenosis who are not candidates for open heart valve surgery. A stenotic aortic valve is narrowed, restricting blood flow from the heart. The TAVR valve is compressed and fed by a catheter (tube) through an artery in the groin (transfemoral approach) or a small incision between the ribs (transapical approach) until it reaches the diseased aortic valve. A balloon expands or wedges the TAVR valve within the patient’s diseased aortic valve and the catheter is removed. The TAVR valve remains in place pushing the diseased valve out of the way, allowing the TAVR valve to take over the job of regulating blood flow.

Aortic Valve in Valve Replacement: commercially available
A minimally invasive TAVR procedure for patients who have had previous open heart valve surgery to replace the aortic valve with a bioprosthetic/tissue valve and the tissue valve is now failing. Instead of the failing aortic tissue valve being replaced during another open heart valve surgery, the failing aortic tissue valve is replaced by placing a TAVR valve inside the failing aortic tissue valve.

Aortic Valve Transcatheter Clinical Trials: 
PARTNER 3, offered at Northwestern Memorial Hospital for select patients at low risk for surgical aortic valve replacement 

GALILEO and REFLECT, offered at Northwestern Memorial Hospital to improve the outcomes of the TAVR procedure

TAVR valve shown in aortic valve position

Tricuspid Valve Transcatheter Treatment Options

Tricuspid Valve Transcatheter Clinical Trials:
SCOUT, offered at Northwestern Memorial Hospital for select patients with tricuspid valve regurgitation

Mark J. Ricciardi, MD
Interventional Cardiology
Procedures performed: TAVR, Aortic Valve in Valve, PARTNER, MitraClip, CardiAQ, TIARA, SCOUT

Ranya N. Sweis, MD
Interventional Cardiology
Procedures performed: TAVR, PARTNER, Aortic Valve in Valve

S. Chris Malaisrie, MD
Cardiac Surgery
Procedures performed: TAVR, Aortic Valve in Valve, PARTNER, MitraClip, CardiAQ, TIARA, SCOUT

Andrei Churyla, MD
Cardiac Surgery
Procedures performed: TAVR, PARTNER, Aortic Valve in Valve, SCOUT

Duc Thinh Pham, MD
Cardiac Surgery
Procedures performed: TAVR, Aortic Valve in Valve, PARTNER, CardiAQ, TIARA, SCOUT

Bluhm Cardiovascular Institute at Central DuPage Hospital
25 N. Winfield Road
Winfield, IL 60190
630.232.0280

Imran N. Ahmad, MD
Interventional Cardiology
Procedures performed: TAVR

Nauman Mushtaq, MD
Interventional Cardiology
Procedures performed: TAVR

Contact Us
For more information regarding transcatheter heart valve therapies, please contact:

Bluhm Cardiovascular Institute at Northwestern Memorial Hospital 312.NM.HEART (664.3278)
or
Bluhm Cardiovascular Institute at Central DuPage Hospital 630.232.0280

Aortic valve in valve replacement

Northwestern Memorial Hospital 312.NM.HEART (312.664.3278)Central DuPage Hospital 630.232.0280

Mitral valve in valve replacement

We are proud of our U.S. News & World Report rankings - a reflection of the leading-edge cardiac and vascular services we offer and the results we achieve for our patients, their families and the region we serve.

  • No. 1 in the Chicago metro region and Illinois for the tenth straight year
  • No. 7 in the nation out of 610 cardiac programs
  • Highest ranked survival score (10 out of 10) for seven consecutive years
  • Highest ranked cardiovascular program in the region: Indiana, Michigan, Wisconsin, Missouri and Iowa

In addition, we are extremely proud to have the highest heart failure survival in the nation for two consecutive years according to the Centers for Medicare and Medicaid Services.